First Time Loading...
B

BioLine RX Ltd
TASE:BLRX

Watchlist Manager
BioLine RX Ltd
TASE:BLRX
Watchlist
Price: 18.1 ILS 3.43% Market Closed
Updated: May 2, 2024
Section:
 

Wall Street
Price Targets

BLRX Price Targets Summary
BioLine RX Ltd

Wall Street analysts forecast BLRX stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BLRX is 3 ILS .

BLRX Lowest Forecast
Wall Street Target
Not Available
BLRX Average Forecast
Wall Street Target
3 ILS
83% Downside
BLRX Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
3 ILS
83% Downside
Highest
Price Target
Not Available
BioLine RX Ltd Competitors:
Price Targets
PRLD
Prelude Therapeutics Inc
59% Upside
KNSA
Kiniksa Pharmaceuticals Ltd
51% Upside
C
CBUS
Cibus Inc
37% Upside
N
688105
Nanjing Vazyme Biotech Co Ltd
56% Upside
PRLD
Prelude Therapeutics Inc
59% Upside
KNSA
Kiniksa Pharmaceuticals Ltd
51% Upside
C
CBUS
Cibus Inc
37% Upside
N
688105
Nanjing Vazyme Biotech Co Ltd
56% Upside
ELEV
Elevation Oncology Inc
98% Upside
Y
301301
Yili Chuanning Biotechnology Co Ltd
20% Downside
688520
Sinocelltech Group Ltd
62% Upside
UTHR
United Therapeutics Corp
17% Upside

Revenue
Forecast

Revenue Estimate
BioLine RX Ltd

Revenue forecast
is not available for
BioLine RX Ltd

Operating Income
Forecast

Operating Income Estimate
BioLine RX Ltd

Operating Income forecast
is not available for
BioLine RX Ltd

Net Income
Forecast

Net Income Estimate
BioLine RX Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
BLRX intrinsic value, competitors valuation, and company profile.
DCF Valuation
BLRX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BLRX stock valuation using valuation multiples.
Wall Street Estimates
BLRX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BLRX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BLRX's stock price target?
Price Target
3 ILS

According to Wall Street analysts, the average 1-year price target for BLRX is 3 ILS .

ALPHA SPREAD
Join more than 133,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.